IMPROVED TECHNOLOGIES PROVIDE RUNNERS WITH ASICS’ MAXIMUM COMFORT TO RUN FURTHER, FOR LONGER
Pune, February 08, 2019: ASICS has announced the launch of the GEL-NIMBUS™ 21 shoe – the latest release of its top-of-the-range, neutral long-distance running shoe. With ASICS’ commitment to continual improvement, the shoe incorporates human-centric science and the latest technology to give long-distance runners superior comfort so they can run further for longer.
Designed for neutral runners, the shoe features ASICS’ latest cushioning technology – FLYTEFOAM™ PROPEL & FLYTEFOAM™ LYTE – resulting in a spring-like feel for a more energetic and lighter run.
Named after the Latin term for the Nimbus cloud formation, the ASICS collection has become synonymous with comfort, with each new release featuring new and improved technology to benefit runners. As the 21st iteration, GEL-NIMBUS™ 21 is no different, incorporating a variety of new technologies including;
Updated features of the GEL-NIMBUS™ 21 include:
To sit alongside the launch of the GEL-Nimbus™ 21, a fully integrated multi-media campaign has been developed, which will stretch across various offline and online media platforms. Fitting in with ASICS’ ‘I MOVE ME’ platform and continuing with its powerful authentic storytelling, there will also be an official campaign video featuring marathon runner and triple Olympic Games athlete Diana Nukuri, which will be available on the ASICS YouTube channel.
Weight: approximately 310 gr (US 9, men)
Heel drop: 10 mm (men), 13 mm (women)
The GEL-NIMBUS™ 21 is available at all ASICS retail and online stores.
Your email address will not be published. Required fields are marked *
Notify me of follow-up comments by email.
Notify me of new posts by email.
Sign me up for the newsletter!
Radhika Bangia Digital Content And Social Media Influencer
UEFA Champions League – Round of 16
Liver transplant patient undergoes laparoscopic bariatric surgery and hernia procedure
Myntra Fashion Upgrade Gets A Mention With Limca Book of Records 2019
Diseases can be nipped in the bud with vaccination as a harm reduction approach
2014 The Global Indian New Network (TGINN)